vTv Therapeutics

Nasdaq VTVT · High Point, NC

Works in Immunology · Metabolic & endocrine · Neurology · Psychiatry

vTv Therapeutics is a clinical trial sponsor based in High Point, NC, listed as Nasdaq VTVT. It has 2 active clinical trials with 190 planned participants, in Immunology, Metabolic & endocrine, Neurology and Psychiatry. Since 2021 it has completed 1 trial and stopped 3 early.

Trial track record · since 2021

2Active trials190 planned participants
1Completed4 with results posted
3Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq VTVT

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 2 active trials

StageTrialStatus

Questions about vTv Therapeutics

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-21.

Approve Suite is not affiliated with vTv Therapeutics.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.